Transcontinental Realty Investors, Inc.

TCI

Transcontinental Realty Investors, Inc. (TCI) is a real estate investment company specializing in the acquisition, development, and management of commercial and multifamily properties. Founded in 1969, TCI focuses on generating value through strategically located investments across various real estate sectors, including retail, office, industrial, and multifamily assets. The company aims to create long-term growth and income for its shareholders through its diversified property portfolio.

$45.61 +0.61 (1.36%)
đźš« Transcontinental Realty Investors, Inc. does not pay dividends

Company News

TC Transcontinental fait l’acquisition d’entreprises du Groupe Canva afin d’accélérer la croissance de ses activités de marketing sur le lieu de vente
GlobeNewswire Inc. • Tc Transcontinental • August 7, 2025

TC Transcontinental has acquired two companies from the Canva Group - Mirazed Inc. and Intergraphics Decal Limited - to strengthen its in-store marketing capabilities in Quebec and Western Canada, adding over 200 skilled employees and advanced production facilities.

U.S. Stocks Turn Higher, Dow Surges More Than 200 Points
Benzinga • Lisa Levin • July 28, 2022

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 200 points on Thursday. The Dow traded up 0.67% to 32,412.36 while the NASDAQ rose 0.39% to 12,079.66. The S&P also rose, gaining, 0.59% to 4,047.22. Also check this: Bitcoin Drops Further To This Level, Here Are Other Crypto Movers That Should Be On Your Radar...

The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Benzinga • Shanthi Rexaline • November 9, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces Procurement Of 1.4M Additional Doses Of COVID-19 Pill By U.S. Merck & Co., Inc. (NYSE: MRK) said its pending acquisition of Acceleron Pharma, Inc. (NASDAQ: XLRN) has been cl...

The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
Benzinga • Shanthi Rexaline • November 8, 2021

Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out to be negative for several others engaged in COVID-19 vaccine and treatment research. Pfizer announced Friday its oral COVID-19 pill Paxlovid reduced the risk of COVID-...

58 Biggest Movers From Yesterday
Benzinga • Lisa Levin • May 19, 2021

Gainers BM Technologies, Inc. (NYSE: BMTX) shares climbed 26.4% to close at $11.82 on Tuesday after the company reported record Q1 results. Ultralife Corporation (NASDAQ: ULBI) jumped 23.4% to close at $10.50 on Tuesday after the company announced it was awarded an IDIQ contract under the US Army's $1.25 billion conformal wearable battery progra...

Related Companies